CA1040271A - Cellule beta artificielle - Google Patents

Cellule beta artificielle

Info

Publication number
CA1040271A
CA1040271A CA218,410A CA218410A CA1040271A CA 1040271 A CA1040271 A CA 1040271A CA 218410 A CA218410 A CA 218410A CA 1040271 A CA1040271 A CA 1040271A
Authority
CA
Canada
Prior art keywords
blood
blood glucose
glucose concentration
rate
means adapted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA218,410A
Other languages
English (en)
Inventor
Anthony M. Albisser
Bernard S. Leibel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Original Assignee
Hospital for Sick Children HSC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC filed Critical Hospital for Sick Children HSC
Priority to CA218,410A priority Critical patent/CA1040271A/fr
Priority to GB1264/76A priority patent/GB1498332A/en
Priority to AU10324/76A priority patent/AU1032476A/en
Priority to FR7601294A priority patent/FR2298832A1/fr
Priority to DE19762601893 priority patent/DE2601893A1/de
Priority to IT47701/76A priority patent/IT1053386B/it
Priority to SE7600588A priority patent/SE7600588L/xx
Priority to JP51006345A priority patent/JPS51125993A/ja
Application granted granted Critical
Publication of CA1040271A publication Critical patent/CA1040271A/fr
Priority to US06/011,601 priority patent/US4245634A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA218,410A 1975-01-22 1975-01-22 Cellule beta artificielle Expired CA1040271A (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA218,410A CA1040271A (fr) 1975-01-22 1975-01-22 Cellule beta artificielle
GB1264/76A GB1498332A (en) 1975-01-22 1976-01-13 Artificial beta cell and computer programmed therefor
AU10324/76A AU1032476A (en) 1975-01-22 1976-01-15 Artificial beta cell
FR7601294A FR2298832A1 (fr) 1975-01-22 1976-01-19 Procede de regulation de
DE19762601893 DE2601893A1 (de) 1975-01-22 1976-01-20 Verfahren und vorrichtung zur regelung der blutzuckerkonzentration von diabetikern
IT47701/76A IT1053386B (it) 1975-01-22 1976-01-20 Cellula beta artificiale con calcolatore e relativo procedimento di applicazione
SE7600588A SE7600588L (sv) 1975-01-22 1976-01-21 Sett att reglera blodglykoskocentrationer i blod, artificiell betacell samt dator for anvendning i en sadan
JP51006345A JPS51125993A (en) 1975-01-22 1976-01-22 Artificial beta cell
US06/011,601 US4245634A (en) 1975-01-22 1979-02-12 Artificial beta cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA218,410A CA1040271A (fr) 1975-01-22 1975-01-22 Cellule beta artificielle

Publications (1)

Publication Number Publication Date
CA1040271A true CA1040271A (fr) 1978-10-10

Family

ID=4102116

Family Applications (1)

Application Number Title Priority Date Filing Date
CA218,410A Expired CA1040271A (fr) 1975-01-22 1975-01-22 Cellule beta artificielle

Country Status (8)

Country Link
JP (1) JPS51125993A (fr)
AU (1) AU1032476A (fr)
CA (1) CA1040271A (fr)
DE (1) DE2601893A1 (fr)
FR (1) FR2298832A1 (fr)
GB (1) GB1498332A (fr)
IT (1) IT1053386B (fr)
SE (1) SE7600588L (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095291A2 (fr) * 1982-05-15 1983-11-30 Kabushiki Kaisha Kyoto Daiichi Kagaku Méthode et appareil pour le mesurage continu d'un constituant spécifié dans un liquide dilué
WO1990001697A1 (fr) * 1988-08-05 1990-02-22 Red Kite Technology Limited Controle de la glycemie
WO2003006091A1 (fr) * 2001-07-11 2003-01-23 The University Of Western Australia Appareil de perfusion pour reguler le taux de glycemie et procedes correspondant
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
US11857763B2 (en) 2016-01-14 2024-01-02 Insulet Corporation Adjusting insulin delivery rates
US11865299B2 (en) 2008-08-20 2024-01-09 Insulet Corporation Infusion pump systems and methods
US11929158B2 (en) 2016-01-13 2024-03-12 Insulet Corporation User interface for diabetes management system
USD1020794S1 (en) 2018-04-02 2024-04-02 Bigfoot Biomedical, Inc. Medication delivery device with icons
USD1024090S1 (en) 2019-01-09 2024-04-23 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11969579B2 (en) 2017-01-13 2024-04-30 Insulet Corporation Insulin delivery methods, systems and devices

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370983A (en) * 1971-01-20 1983-02-01 Lichtenstein Eric Stefan Computer-control medical care system
DE2737922A1 (de) * 1977-08-23 1979-03-08 Fresenius Chem Pharm Ind Kuenstliche endokrine druese
US4151845A (en) * 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
US4469681A (en) * 1979-07-31 1984-09-04 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
US4348387A (en) * 1979-07-31 1982-09-07 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
JPS598969A (ja) * 1982-07-09 1984-01-18 藤沢薬品工業株式会社 人工膵臓
FR2531333B1 (fr) * 1982-08-09 1986-04-04 Centre Nat Rech Scient Pancreas bio-artificiel a ultrafiltration
DD230730A3 (de) * 1984-01-02 1985-12-11 Zentralinstitut Fuer Diabetes Einrichtung zur prospektiven automatischen bestimmung individualspezifischer glukoseregulationsparameter
CA1254091A (fr) * 1984-09-28 1989-05-16 Vladimir Feingold Systeme implantable pour la perfusion de medicaments
DE3545260A1 (de) * 1985-12-20 1987-06-25 Juergen Schrezenmeir Vorrichtung zur kontinuierlichen oder diskontinuierlichen verabreichung von insulin in den menschlichen koerper
US7384396B2 (en) 1998-07-21 2008-06-10 Spectrx Inc. System and method for continuous analyte monitoring
US7037277B1 (en) 1998-07-21 2006-05-02 Spectrx, Inc. System and method for fluid management in a continuous fluid collection and sensor device
CA3105353A1 (fr) * 2007-10-10 2009-04-16 Optiscan Biomedical Corporation Systeme d'analyse de composant de fluide et procede pour controler et reguler le glucose
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
WO2016134137A1 (fr) 2015-02-18 2016-08-25 Insulet Corporation Dispositifs de perfusion et de distribution de fluide, et leurs procédés d'utilisation
WO2018058041A1 (fr) 2016-09-23 2018-03-29 Insulet Corporation Dispositif d'administration de fluide avec capteur
CA3099113A1 (fr) 2018-05-04 2019-11-07 Insulet Corporation Contraintes de securite pour un systeme d'administration de medicament base sur un algorithme de commande
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
WO2020077223A1 (fr) 2018-10-11 2020-04-16 Insulet Corporation Détection d'événement pour système d'administration de médicament
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4354455A3 (fr) 2019-12-06 2024-07-10 Insulet Corporation Techniques et dispositifs fournissant une adaptivité et une personnalisation dans le traitement du diabète
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US11738144B2 (en) 2021-09-27 2023-08-29 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095291A2 (fr) * 1982-05-15 1983-11-30 Kabushiki Kaisha Kyoto Daiichi Kagaku Méthode et appareil pour le mesurage continu d'un constituant spécifié dans un liquide dilué
EP0095291A3 (en) * 1982-05-15 1984-03-21 Kabushiki Kaisha Kyoto Daiichi Kagaku Continuous measurement of the concentration of a predetermined ingredient in a diluted liquid
WO1990001697A1 (fr) * 1988-08-05 1990-02-22 Red Kite Technology Limited Controle de la glycemie
WO2003006091A1 (fr) * 2001-07-11 2003-01-23 The University Of Western Australia Appareil de perfusion pour reguler le taux de glycemie et procedes correspondant
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
US11865299B2 (en) 2008-08-20 2024-01-09 Insulet Corporation Infusion pump systems and methods
US11929158B2 (en) 2016-01-13 2024-03-12 Insulet Corporation User interface for diabetes management system
US11857763B2 (en) 2016-01-14 2024-01-02 Insulet Corporation Adjusting insulin delivery rates
US11969579B2 (en) 2017-01-13 2024-04-30 Insulet Corporation Insulin delivery methods, systems and devices
USD1020794S1 (en) 2018-04-02 2024-04-02 Bigfoot Biomedical, Inc. Medication delivery device with icons
USD1024090S1 (en) 2019-01-09 2024-04-23 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery

Also Published As

Publication number Publication date
AU1032476A (en) 1977-07-21
DE2601893A1 (de) 1976-07-29
SE7600588L (sv) 1976-07-23
GB1498332A (en) 1978-01-18
IT1053386B (it) 1981-08-31
FR2298832A1 (fr) 1976-08-20
JPS51125993A (en) 1976-11-02

Similar Documents

Publication Publication Date Title
CA1040271A (fr) Cellule beta artificielle
US4245634A (en) Artificial beta cell
Albisser et al. Clinical control of diabetes by the artificial pancreas
Albisser et al. An artificial endocrine pancreas
Mirouze et al. Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes
Christiansen et al. Kidney function and size in diabetics before and during initial insulin treatment
US7354420B2 (en) Closed loop system for controlling insulin infusion
CA1121243A (fr) Appareil pour regler la glycemie
Sulli et al. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia
Shichiri et al. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell
US20080188796A1 (en) Closed-Loop Method for Controlling Insulin Infusion
US20040193025A1 (en) Closed-loop method for controlling insulin infusion
Wiseman et al. Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes
Service et al. Characteristics of glycemic stability
Albisser Devices for the control of diabetes mellitus
EP1382363A1 (fr) Systéme en boucle fermée de gestion pour contrôler les niveaux de taux de glucose sanguin
Schiffrin et al. Intensified insulin therapy in the type I diabetic adolescent: a controlled trial
Meyer et al. Diabetic management by insulin infusion during major surgery
GB1574267A (en) Apparatus for controlling a quantity of insulin infusion
Rønn et al. Evaluation of insulin pump treatment under routine conditions
Freckmann et al. Recent advances in continuous glucose monitoring
Sherwin et al. Treatment of juvenile-onset diabetes by subcutaneous infusion of insulin with a portable pump
MERIN et al. Major inhalation anesthetics and carbohydrate metabolism
Clarke et al. Clinical evaluation and preliminary studies on the use of an artificial pancreatic beta cell in juvenile diabetes mellitus
Horwitz et al. Hyperinsulinism complicating control of diabetes mellitus by an artificial beta-cell